Skip to main content

Demographics of study population

“Key characteristics of study participants”

Baseline demographic information is presented in Table 1 alongside average baseline HbA1c, with the main findings outlined below: 

  • Average baseline blood sugar levels were almost identical between the two groups (treatment 43.7 mmol/mol vs. comparison 43.6 mmol/mol) 
  • Both groups showed a high level of obesity 
  • However, there were some differences. Over half of both groups were aged 65+ years, but those in the treatment group were, on average, 2 years younger 
  • A higher proportion of participants in the treatment group were male, and lived in the two most deprived  quintiles 

Table 1. Baseline profile of treatment and comparison groups

   

Treatment Group

(n = 1,970)

Comparison Group

(n = 1,494) 

 P
Baseline HbA1c  Mean 43.7 mmol/mol  43.6 mmol/mol  n/a
SD 1.6 1.6
Age  Mean 64.2 years  66.0 years <0.05 
SD 11.4  13.5
 
Min 20 years 18 years  
Max 93 years 100 years
Age Group 18-49 217 (11.0%) 164 (11.0%)  0.07
50-64 708 (35.9%) 483 (32.3%) 
 
 
65+ 1,045 (53.1%)  847 (56.7%) 
Sex Male 959 (48.7%)   656 (43.9%)  <0.05 
Female 1,011 (51.3%)  548 (56.1%)
WIMD Most Deprived  589 (29.9%) 412 (27.6%)  <0.05
2 499 (25.3%)  342 (22.9%) 
3 371 (18.8%)  266 (17.8%) 
4 257 (13.1%) 231 (15.5%) 
Least Deprived  253 (12.8%)  243 (16.3%) 
BMI Class*  Healthy to Overweight  267 (40.2%)  154 (40.2%) 0.33 
  Obesity Class 1  207 (31.1%)  105 (27.4%)   
  Obesity Class 2-3  191 (28.7%)  124 (32.4%)  

*Partial data. Treatment group (n = 665), comparison group (n = 383)